English
简体中文
Total: £ 56.28
Published Date: 2026-04-08 | Pages: 126 | Tables: 133 | Pharma & Healthcare
The global Women's Health market was valued at US$ 36700 million in 2025 and is anticipated to reach US$ 47790 million by 2032, at a CAGR of 3.9% from 2026 to 2032.
Women's health refers to the branch of healthcare that focuses on the unique medical needs of women throughout different stages of life, from puberty to menopause and beyond. It includes a wide range of conditions and treatments related to reproductive health, hormonal imbalances, pregnancy, breast health, osteoporosis, and mental well-being. Women's health also covers issues like sexual health, contraception, fertility, and gynecological diseases such as endometriosis and polycystic ovary syndrome (PCOS). Recognizing that women experience health issues differently than men, this field emphasizes gender-specific research and treatments tailored to the physiological, psychological, and social needs of women.
Market Driver: The increasing focus on women’s health, driven by a combination of greater awareness, advocacy, and healthcare advancements, is a major driver of the women’s health market. As women continue to seek more personalized and comprehensive care, demand for treatments addressing conditions like reproductive health, menopause, osteoporosis, breast cancer, and mental health is on the rise. This is further supported by the growing recognition of the need for gender-specific healthcare solutions, including pharmaceuticals, diagnostics, and wellness products. Additionally, the rise in women’s life expectancy and the increasing number of women in the workforce who are able to access healthcare resources have also contributed to the growth of this market.
Market Challenge: Despite the growing demand for women’s health products and services, the market faces several challenges, including underrepresentation of women in clinical research and the lack of tailored treatments for gender-specific health issues. Many medical studies have historically been conducted with a male-dominated sample, which leads to insufficient data on how treatments affect women differently. Moreover, there are still significant social and cultural barriers in certain regions that prevent women from accessing adequate healthcare or seeking treatments for issues like reproductive health or menopause. These challenges can slow market growth, limit access, and hinder the development of more effective and personalized care for women.
The main companies of Global Women's Health include Amgen, Bayer, Merck KGaA, etc. These top three companies hold a market share about 20%. Europe and North America are the leading production regions in the world. The product is mainly used in contraceptive pills.
This report delivers a comprehensive overview of the global Women's Health market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Women's Health. The Women's Health market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Women's Health market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Women's Health manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Amgen
Bayer
Merck KGaA
Merck & Co
Ferring
Eli Lilly
Pfizer
AbbVie
Abbott
Theramex
Livzon Pharmaceuticals
Foundation Consumer Healthcare
Xianjun Pharmaceuticals
Zizhu Pharmaceuticals
Qianjin Pharmaceuticals
Organon Pharma
Insud Pharma
Viatris
Teva
Hisamitsu
Segment by Type
Hormone Therapy
Nonhormonal Therapy
Segment by Application
Climacteric
Postmenopausal Osteoporosis
Contraceptive Pill
Infertility
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Women's Health companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Women's Health Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Hormone Therapy
1.2.3 Nonhormonal Therapy
1.3 Market by Application
1.3.1 Global Women's Health Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Climacteric
1.3.3 Postmenopausal Osteoporosis
1.3.4 Contraceptive Pill
1.3.5 Infertility
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Women's Health Market Perspective (2021–2032)
2.2 Global Women's Health Growth Trends by Region
2.2.1 Global Women's Health Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Women's Health Historic Market Size by Region (2021–2026)
2.2.3 Women's Health Forecasted Market Size by Region (2027–2032)
2.3 Women's Health Market Dynamics
2.3.1 Women's Health Industry Trends
2.3.2 Women's Health Market Drivers
2.3.3 Women's Health Market Challenges
2.3.4 Women's Health Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Women's Health Players by Revenue
3.1.1 Global Top Women's Health Players by Revenue (2021–2026)
3.1.2 Global Women's Health Revenue Market Share by Players (2021–2026)
3.2 Global Top Women's Health Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Women's Health Revenue
3.4 Global Women's Health Market Concentration Ratio
3.4.1 Global Women's Health Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Women's Health Revenue in 2025
3.5 Global Key Players of Women's Health Head Offices and Areas Served
3.6 Global Key Players of Women's Health, Products and Applications
3.7 Global Key Players of Women's Health, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Women's Health Breakdown Data by Type
4.1 Global Women's Health Historic Market Size by Type (2021–2026)
4.2 Global Women's Health Forecasted Market Size by Type (2027–2032)
5 Women's Health Breakdown Data by Application
5.1 Global Women's Health Historic Market Size by Application (2021–2026)
5.2 Global Women's Health Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Women's Health Market Size (2021–2032)
6.2 North America Women's Health Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Women's Health Market Size by Country (2021–2026)
6.4 North America Women's Health Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Women's Health Market Size (2021–2032)
7.2 Europe Women's Health Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Women's Health Market Size by Country (2021–2026)
7.4 Europe Women's Health Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Women's Health Market Size (2021–2032)
8.2 Asia-Pacific Women's Health Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Women's Health Market Size by Region (2021–2026)
8.4 Asia-Pacific Women's Health Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Women's Health Market Size (2021–2032)
9.2 Latin America Women's Health Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Women's Health Market Size by Country (2021–2026)
9.4 Latin America Women's Health Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Women's Health Market Size (2021–2032)
10.2 Middle East & Africa Women's Health Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Women's Health Market Size by Country (2021–2026)
10.4 Middle East & Africa Women's Health Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Women's Health Introduction
11.1.4 Amgen Revenue in Women's Health Business (2021–2026)
11.1.5 Amgen Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Women's Health Introduction
11.2.4 Bayer Revenue in Women's Health Business (2021–2026)
11.2.5 Bayer Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Details
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Women's Health Introduction
11.3.4 Merck KGaA Revenue in Women's Health Business (2021–2026)
11.3.5 Merck KGaA Recent Development
11.4 Merck & Co
11.4.1 Merck & Co Company Details
11.4.2 Merck & Co Business Overview
11.4.3 Merck & Co Women's Health Introduction
11.4.4 Merck & Co Revenue in Women's Health Business (2021–2026)
11.4.5 Merck & Co Recent Development
11.5 Ferring
11.5.1 Ferring Company Details
11.5.2 Ferring Business Overview
11.5.3 Ferring Women's Health Introduction
11.5.4 Ferring Revenue in Women's Health Business (2021–2026)
11.5.5 Ferring Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Women's Health Introduction
11.6.4 Eli Lilly Revenue in Women's Health Business (2021–2026)
11.6.5 Eli Lilly Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Women's Health Introduction
11.7.4 Pfizer Revenue in Women's Health Business (2021–2026)
11.7.5 Pfizer Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Women's Health Introduction
11.8.4 AbbVie Revenue in Women's Health Business (2021–2026)
11.8.5 AbbVie Recent Development
11.9 Abbott
11.9.1 Abbott Company Details
11.9.2 Abbott Business Overview
11.9.3 Abbott Women's Health Introduction
11.9.4 Abbott Revenue in Women's Health Business (2021–2026)
11.9.5 Abbott Recent Development
11.10 Theramex
11.10.1 Theramex Company Details
11.10.2 Theramex Business Overview
11.10.3 Theramex Women's Health Introduction
11.10.4 Theramex Revenue in Women's Health Business (2021–2026)
11.10.5 Theramex Recent Development
11.11 Livzon Pharmaceuticals
11.11.1 Livzon Pharmaceuticals Company Details
11.11.2 Livzon Pharmaceuticals Business Overview
11.11.3 Livzon Pharmaceuticals Women's Health Introduction
11.11.4 Livzon Pharmaceuticals Revenue in Women's Health Business (2021–2026)
11.11.5 Livzon Pharmaceuticals Recent Development
11.12 Foundation Consumer Healthcare
11.12.1 Foundation Consumer Healthcare Company Details
11.12.2 Foundation Consumer Healthcare Business Overview
11.12.3 Foundation Consumer Healthcare Women's Health Introduction
11.12.4 Foundation Consumer Healthcare Revenue in Women's Health Business (2021–2026)
11.12.5 Foundation Consumer Healthcare Recent Development
11.13 Xianjun Pharmaceuticals
11.13.1 Xianjun Pharmaceuticals Company Details
11.13.2 Xianjun Pharmaceuticals Business Overview
11.13.3 Xianjun Pharmaceuticals Women's Health Introduction
11.13.4 Xianjun Pharmaceuticals Revenue in Women's Health Business (2021–2026)
11.13.5 Xianjun Pharmaceuticals Recent Development
11.14 Zizhu Pharmaceuticals
11.14.1 Zizhu Pharmaceuticals Company Details
11.14.2 Zizhu Pharmaceuticals Business Overview
11.14.3 Zizhu Pharmaceuticals Women's Health Introduction
11.14.4 Zizhu Pharmaceuticals Revenue in Women's Health Business (2021–2026)
11.14.5 Zizhu Pharmaceuticals Recent Development
11.15 Qianjin Pharmaceuticals
11.15.1 Qianjin Pharmaceuticals Company Details
11.15.2 Qianjin Pharmaceuticals Business Overview
11.15.3 Qianjin Pharmaceuticals Women's Health Introduction
11.15.4 Qianjin Pharmaceuticals Revenue in Women's Health Business (2021–2026)
11.15.5 Qianjin Pharmaceuticals Recent Development
11.16 Organon Pharma
11.16.1 Organon Pharma Company Details
11.16.2 Organon Pharma Business Overview
11.16.3 Organon Pharma Women's Health Introduction
11.16.4 Organon Pharma Revenue in Women's Health Business (2021–2026)
11.16.5 Organon Pharma Recent Development
11.17 Insud Pharma
11.17.1 Insud Pharma Company Details
11.17.2 Insud Pharma Business Overview
11.17.3 Insud Pharma Women's Health Introduction
11.17.4 Insud Pharma Revenue in Women's Health Business (2021–2026)
11.17.5 Insud Pharma Recent Development
11.18 Viatris
11.18.1 Viatris Company Details
11.18.2 Viatris Business Overview
11.18.3 Viatris Women's Health Introduction
11.18.4 Viatris Revenue in Women's Health Business (2021–2026)
11.18.5 Viatris Recent Development
11.19 Teva
11.19.1 Teva Company Details
11.19.2 Teva Business Overview
11.19.3 Teva Women's Health Introduction
11.19.4 Teva Revenue in Women's Health Business (2021–2026)
11.19.5 Teva Recent Development
11.20 Hisamitsu
11.20.1 Hisamitsu Company Details
11.20.2 Hisamitsu Business Overview
11.20.3 Hisamitsu Women's Health Introduction
11.20.4 Hisamitsu Revenue in Women's Health Business (2021–2026)
11.20.5 Hisamitsu Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Women's Health Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Hormone Therapy
Table 3. Key Players of Nonhormonal Therapy
Table 4. Global Women's Health Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Women's Health Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Women's Health Market Size by Region (US$ Million), 2021–2026
Table 7. Global Women's Health Market Share by Region (2021–2026)
Table 8. Global Women's Health Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Women's Health Market Share by Region (2027–2032)
Table 10. Women's Health Market Trends
Table 11. Women's Health Market Drivers
Table 12. Women's Health Market Challenges
Table 13. Women's Health Market Restraints
Table 14. Global Women's Health Revenue by Players (US$ Million), 2021–2026
Table 15. Global Women's Health Market Share by Players (2021–2026)
Table 16. Global Top Women's Health Players by Tier (Tier 1, Tier 2, and Tier 3), based on Women's Health Revenue, 2025
Table 17. Ranking of Global Top Women's Health Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Women's Health Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Women's Health, Headquarters and Area Served
Table 20. Global Key Players of Women's Health, Products and Applications
Table 21. Global Key Players of Women's Health, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Women's Health Market Size by Type (US$ Million), 2021–2026
Table 24. Global Women's Health Revenue Market Share by Type (2021–2026)
Table 25. Global Women's Health Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Women's Health Revenue Market Share by Type (2027–2032)
Table 27. Global Women's Health Market Size by Application (US$ Million), 2021–2026
Table 28. Global Women's Health Revenue Market Share by Application (2021–2026)
Table 29. Global Women's Health Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Women's Health Revenue Market Share by Application (2027–2032)
Table 31. North America Women's Health Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Women's Health Market Size by Country (US$ Million), 2021–2026
Table 33. North America Women's Health Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Women's Health Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Women's Health Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Women's Health Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Women's Health Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Women's Health Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Women's Health Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Women's Health Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Women's Health Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Women's Health Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Women's Health Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Women's Health Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Women's Health Market Size by Country (US$ Million), 2027–2032
Table 46. Amgen Company Details
Table 47. Amgen Business Overview
Table 48. Amgen Women's Health Product
Table 49. Amgen Revenue in Women's Health Business (US$ Million), 2021–2026
Table 50. Amgen Recent Development
Table 51. Bayer Company Details
Table 52. Bayer Business Overview
Table 53. Bayer Women's Health Product
Table 54. Bayer Revenue in Women's Health Business (US$ Million), 2021–2026
Table 55. Bayer Recent Development
Table 56. Merck KGaA Company Details
Table 57. Merck KGaA Business Overview
Table 58. Merck KGaA Women's Health Product
Table 59. Merck KGaA Revenue in Women's Health Business (US$ Million), 2021–2026
Table 60. Merck KGaA Recent Development
Table 61. Merck & Co Company Details
Table 62. Merck & Co Business Overview
Table 63. Merck & Co Women's Health Product
Table 64. Merck & Co Revenue in Women's Health Business (US$ Million), 2021–2026
Table 65. Merck & Co Recent Development
Table 66. Ferring Company Details
Table 67. Ferring Business Overview
Table 68. Ferring Women's Health Product
Table 69. Ferring Revenue in Women's Health Business (US$ Million), 2021–2026
Table 70. Ferring Recent Development
Table 71. Eli Lilly Company Details
Table 72. Eli Lilly Business Overview
Table 73. Eli Lilly Women's Health Product
Table 74. Eli Lilly Revenue in Women's Health Business (US$ Million), 2021–2026
Table 75. Eli Lilly Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Women's Health Product
Table 79. Pfizer Revenue in Women's Health Business (US$ Million), 2021–2026
Table 80. Pfizer Recent Development
Table 81. AbbVie Company Details
Table 82. AbbVie Business Overview
Table 83. AbbVie Women's Health Product
Table 84. AbbVie Revenue in Women's Health Business (US$ Million), 2021–2026
Table 85. AbbVie Recent Development
Table 86. Abbott Company Details
Table 87. Abbott Business Overview
Table 88. Abbott Women's Health Product
Table 89. Abbott Revenue in Women's Health Business (US$ Million), 2021–2026
Table 90. Abbott Recent Development
Table 91. Theramex Company Details
Table 92. Theramex Business Overview
Table 93. Theramex Women's Health Product
Table 94. Theramex Revenue in Women's Health Business (US$ Million), 2021–2026
Table 95. Theramex Recent Development
Table 96. Livzon Pharmaceuticals Company Details
Table 97. Livzon Pharmaceuticals Business Overview
Table 98. Livzon Pharmaceuticals Women's Health Product
Table 99. Livzon Pharmaceuticals Revenue in Women's Health Business (US$ Million), 2021–2026
Table 100. Livzon Pharmaceuticals Recent Development
Table 101. Foundation Consumer Healthcare Company Details
Table 102. Foundation Consumer Healthcare Business Overview
Table 103. Foundation Consumer Healthcare Women's Health Product
Table 104. Foundation Consumer Healthcare Revenue in Women's Health Business (US$ Million), 2021–2026
Table 105. Foundation Consumer Healthcare Recent Development
Table 106. Xianjun Pharmaceuticals Company Details
Table 107. Xianjun Pharmaceuticals Business Overview
Table 108. Xianjun Pharmaceuticals Women's Health Product
Table 109. Xianjun Pharmaceuticals Revenue in Women's Health Business (US$ Million), 2021–2026
Table 110. Xianjun Pharmaceuticals Recent Development
Table 111. Zizhu Pharmaceuticals Company Details
Table 112. Zizhu Pharmaceuticals Business Overview
Table 113. Zizhu Pharmaceuticals Women's Health Product
Table 114. Zizhu Pharmaceuticals Revenue in Women's Health Business (US$ Million), 2021–2026
Table 115. Zizhu Pharmaceuticals Recent Development
Table 116. Qianjin Pharmaceuticals Company Details
Table 117. Qianjin Pharmaceuticals Business Overview
Table 118. Qianjin Pharmaceuticals Women's Health Product
Table 119. Qianjin Pharmaceuticals Revenue in Women's Health Business (US$ Million), 2021–2026
Table 120. Qianjin Pharmaceuticals Recent Development
Table 121. Organon Pharma Company Details
Table 122. Organon Pharma Business Overview
Table 123. Organon Pharma Women's Health Product
Table 124. Organon Pharma Revenue in Women's Health Business (US$ Million), 2021–2026
Table 125. Organon Pharma Recent Development
Table 126. Insud Pharma Company Details
Table 127. Insud Pharma Business Overview
Table 128. Insud Pharma Women's Health Product
Table 129. Insud Pharma Revenue in Women's Health Business (US$ Million), 2021–2026
Table 130. Insud Pharma Recent Development
Table 131. Viatris Company Details
Table 132. Viatris Business Overview
Table 133. Viatris Women's Health Product
Table 134. Viatris Revenue in Women's Health Business (US$ Million), 2021–2026
Table 135. Viatris Recent Development
Table 136. Teva Company Details
Table 137. Teva Business Overview
Table 138. Teva Women's Health Product
Table 139. Teva Revenue in Women's Health Business (US$ Million), 2021–2026
Table 140. Teva Recent Development
Table 141. Hisamitsu Company Details
Table 142. Hisamitsu Business Overview
Table 143. Hisamitsu Women's Health Product
Table 144. Hisamitsu Revenue in Women's Health Business (US$ Million), 2021–2026
Table 145. Hisamitsu Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
Table 149. Authors List of This Report
List of Figures
Figure 1. Women's Health Picture
Figure 2. Global Women's Health Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Women's Health Market Share by Type: 2025 vs 2032
Figure 4. Hormone Therapy Features
Figure 5. Nonhormonal Therapy Features
Figure 6. Global Women's Health Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Women's Health Market Share by Application: 2025 vs 2032
Figure 8. Climacteric Case Studies
Figure 9. Postmenopausal Osteoporosis Case Studies
Figure 10. Contraceptive Pill Case Studies
Figure 11. Infertility Case Studies
Figure 12. Others Case Studies
Figure 13. Women's Health Report Years Considered
Figure 14. Global Women's Health Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Women's Health Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Women's Health Market Share by Region: 2025 vs 2032
Figure 17. Global Women's Health Market Share by Players in 2025
Figure 18. Global Women's Health Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Women's Health Revenue in 2025
Figure 20. North America Women's Health Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Women's Health Market Share by Country (2021–2032)
Figure 22. United States Women's Health Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Women's Health Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Women's Health Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Women's Health Market Share by Country (2021–2032)
Figure 26. Germany Women's Health Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Women's Health Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Women's Health Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Women's Health Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Women's Health Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Women's Health Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Women's Health Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Women's Health Market Share by Region (2021–2032)
Figure 34. China Women's Health Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Women's Health Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Women's Health Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Women's Health Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Women's Health Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Women's Health Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Women's Health Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Women's Health Market Share by Country (2021–2032)
Figure 42. Mexico Women's Health Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Women's Health Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Women's Health Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Women's Health Market Share by Country (2021–2032)
Figure 46. Israel Women's Health Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Women's Health Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Women's Health Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Amgen Revenue Growth Rate in Women's Health Business (2021–2026)
Figure 50. Bayer Revenue Growth Rate in Women's Health Business (2021–2026)
Figure 51. Merck KGaA Revenue Growth Rate in Women's Health Business (2021–2026)
Figure 52. Merck & Co Revenue Growth Rate in Women's Health Business (2021–2026)
Figure 53. Ferring Revenue Growth Rate in Women's Health Business (2021–2026)
Figure 54. Eli Lilly Revenue Growth Rate in Women's Health Business (2021–2026)
Figure 55. Pfizer Revenue Growth Rate in Women's Health Business (2021–2026)
Figure 56. AbbVie Revenue Growth Rate in Women's Health Business (2021–2026)
Figure 57. Abbott Revenue Growth Rate in Women's Health Business (2021–2026)
Figure 58. Theramex Revenue Growth Rate in Women's Health Business (2021–2026)
Figure 59. Livzon Pharmaceuticals Revenue Growth Rate in Women's Health Business (2021–2026)
Figure 60. Foundation Consumer Healthcare Revenue Growth Rate in Women's Health Business (2021–2026)
Figure 61. Xianjun Pharmaceuticals Revenue Growth Rate in Women's Health Business (2021–2026)
Figure 62. Zizhu Pharmaceuticals Revenue Growth Rate in Women's Health Business (2021–2026)
Figure 63. Qianjin Pharmaceuticals Revenue Growth Rate in Women's Health Business (2021–2026)
Figure 64. Organon Pharma Revenue Growth Rate in Women's Health Business (2021–2026)
Figure 65. Insud Pharma Revenue Growth Rate in Women's Health Business (2021–2026)
Figure 66. Viatris Revenue Growth Rate in Women's Health Business (2021–2026)
Figure 67. Teva Revenue Growth Rate in Women's Health Business (2021–2026)
Figure 68. Hisamitsu Revenue Growth Rate in Women's Health Business (2021–2026)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
